Adam C Steinberg1, Megan O Schimpf2, Amanda B White3, Cara Mathews4, David R Ellington5, Peter Jeppson6, Catrina Crisp7, Sarit O Aschkenazi8, Mamta M Mamik9, Ethan M Balk10, Miles Murphy11. 1. Division of Urogynecology, Hartford Hospital University of the Connecticut School of Medicine, Hartford, CT. Electronic address: acsteinberg06@yahoo.com. 2. Division of Gynecology, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI. 3. Department of Obstetrics and Gynecology, University of Texas Southwestern at Seton Healthcare Family, Austin, TX. 4. Division of Gynecology-Oncology, Department of Obstetrics and Gynecology, Alpert Medical School, Brown University, Providence, RI. 5. Division of Urogynecology and Pelvic Reconstruction, University of Alabama at Birmingham, Birmingham, AL. 6. Division of Urogynecology, University of New Mexico, Albuquerque, NM. 7. Division of Urogynecology, Tri Health, Cincinnati, OH. 8. Department of Urogynecology, ProHealth Care, Women's Center, Medical College of Wisconsin, Waukesha, WI. 9. Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY. 10. Center for Evidence-Based Medicine, Brown University School of Public Health, Providence, RI. 11. Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, PA.
Abstract
OBJECTIVE: The objective of the study was to investigate the effectiveness of preemptive analgesia at pain control in women undergoing total abdominal hysterectomy. DATA SOURCES: Eligible studies, published through May 31, 2016, were retrieved through Medline, Cochrane Central Register for Controlled Trials, and Cochrane Database of Systematic Reviews. STUDY ELIGIBILITY: We included randomized controlled trials with the primary outcome of pain control in women receiving a preemptive medication prior to total abdominal hysterectomy. Comparators were placebo, different doses of the same medication as intervention, or other nonnarcotic or narcotic medication. STUDY APPRAISAL AND SYNTHESIS METHODS: Study data were extracted by one reviewer and confirmed by a second reviewer. For each outcome we graded the quality of the evidence. Studies were classified by the type of medication used and by outcome type. RESULTS: Eighty-four trials met eligibility, with 69 included. Among nonnarcotic medications, paracetamol, gabapentin, and rofecoxib combined with gabapentin resulted in improvements in pain assessment compared with placebo and other nonnarcotic medications. Patient satisfaction was higher in patients who were given gabapentin combined with paracetamol compared with gabapentin alone. Use of preemptive paracetamol, gabapentin, bupivacaine, and phenothiazine resulted in less narcotic usage than placebo. All narcotics (ketamine, morphine, fentanyl) resulted in improved pain control compared with placebo. Narcotics had a greater reduction in pain assessment scores compared with nonnarcotics, and their use resulted in lower total narcotic usage. CONCLUSION: Preemptive nonnarcotic and narcotic medications prior to abdominal hysterectomy decrease total narcotic requirements and improve patient postoperative pain assessment and satisfaction scores.
OBJECTIVE: The objective of the study was to investigate the effectiveness of preemptive analgesia at pain control in women undergoing total abdominal hysterectomy. DATA SOURCES: Eligible studies, published through May 31, 2016, were retrieved through Medline, Cochrane Central Register for Controlled Trials, and Cochrane Database of Systematic Reviews. STUDY ELIGIBILITY: We included randomized controlled trials with the primary outcome of pain control in women receiving a preemptive medication prior to total abdominal hysterectomy. Comparators were placebo, different doses of the same medication as intervention, or other nonnarcotic or narcotic medication. STUDY APPRAISAL AND SYNTHESIS METHODS: Study data were extracted by one reviewer and confirmed by a second reviewer. For each outcome we graded the quality of the evidence. Studies were classified by the type of medication used and by outcome type. RESULTS: Eighty-four trials met eligibility, with 69 included. Among nonnarcotic medications, paracetamol, gabapentin, and rofecoxib combined with gabapentin resulted in improvements in pain assessment compared with placebo and other nonnarcotic medications. Patient satisfaction was higher in patients who were given gabapentin combined with paracetamol compared with gabapentin alone. Use of preemptive paracetamol, gabapentin, bupivacaine, and phenothiazine resulted in less narcotic usage than placebo. All narcotics (ketamine, morphine, fentanyl) resulted in improved pain control compared with placebo. Narcotics had a greater reduction in pain assessment scores compared with nonnarcotics, and their use resulted in lower total narcotic usage. CONCLUSION: Preemptive nonnarcotic and narcotic medications prior to abdominal hysterectomy decrease total narcotic requirements and improve patientpostoperative pain assessment and satisfaction scores.
Authors: Catherine N Vu; Carol M Lewis; Neil S Bailard; Ravish Kapoor; M Laura Rubin; Gang Zheng Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-06-18 Impact factor: 6.223
Authors: Chung Hun Lee; Soo Ah Cho; Seok Kyeong Oh; Sang Sik Choi; Myoung Hoon Kong; Young Sung Kim Journal: BMC Anesthesiol Date: 2022-07-07 Impact factor: 2.376
Authors: Raymond C Tait; Kim Zoberi; McKenzie Ferguson; Kimberly Levenhagen; Rebecca A Luebbert; Kevin Rowland; Gretchen B Salsich; Christopher Herndon Journal: J Pain Date: 2018-06-30 Impact factor: 5.820